ViaCyte, a beta cell technology company funded by JDRF, has been awarded a Small Business Innovative Research (SBIR) Phase II Award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support the further development of its work. In read more »

JDRF’s One Walks are taking place across the UK, giving you the chance to help raise money for Type 1 diabetes research. A global event to walk for the future of Type 1 diabetes research, One Walks began in 2014 and have read more »

The Ascensia Diabetes Challenge was launched last September. A global innovation competition, it was introduced to fine digital solutions to support Type 2 diabetes management. The many entries have been narrowed down to six that will progress to the finalist stage of read more »

As reported in Fierce Biotech, in America Semma Therapeutics has raised $114 million to take a potentially-curative Type 1 diabetes cell therapy through clinical proof of concept. The funding round positions Semma to start learning whether its insulin-producing cells can control blood read more »

Researchers at Leeds Beckett University are seeking volunteers with Type 1 diabetes to take part in a new study looking to determine whether omega-3 supplements can improve the day-to-day management of Type 1 diabetes. The study is led by Dr Matthew Campbell, read more »

Diabetes kit that’s coming soon: An interview with Dr. Philip Toleikis of Sernova Corp, based in London, Ontario, Canada about the company’s Cell Pouch and immune protected cell technologies, referred to as a regenerative medicine solution in development. The company’s stated aim read more »

The BiAP is the bio-inspired artificial pancreas. We have an update on progress of this British-based endeavour. Moving overseas, we have another research report on Cell Pouch technology being researched in Canada. This is an implantable matrix that can hold stem beta read more »

A new way of holding insulin producing islet cells inside the body has been developed at the Royal Adelaide Hospital in southern Australia, where doctors have been trialling artificial skin, already used globally in burns injuries, as a potential site for the read more »

Researchers at Lund University in Sweden have found a new type of biomarker that can predict the risk of Type 2 diabetes, by detecting epigenetic changes in specific genes through a simple blood test. The results were published in Nature Communications. “This could read more »

A glucogen powder now in development by Eli Lilly to treat dangerously low blood sugar in patients with Type 1 diabetes, the goal being to replace the large needles now available (but seldom used) to inject glucogen during hypoglycaemic attacks with an read more »